BUSINESS Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman Tuesday, March 10, 2026 · hagens berman sobol shapiro llp Advertisement Read Original Article → Related Dispatches [EU] · Jun 29 China Sets 1.25% Overnight Reverse Repo Rate Below Market Expectations [CA] · Jun 29 Politics And The Markets 06/29/26 [EU] · Jun 29 Idaho National Laboratory - Improving biomass yield: New models could help biorefineries accommodate their unique needs